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Background: Joint hypermobility is a common clinical characteristic of patients with Osteogenesis imperfecta (OI),
a disorder with serious comorbidities of scoliosis and cranial base anomalies. This study aimed at evaluating how
prevalent joint hypermobility is in paediatric OI patients, and to find out whether it serves as a potential predictive
marker of the different spinal complications; scoliosis and craniovertebral anomalies (basilar impression and basilar
invagination).
Methods: In this cross-sectional one-center study we analysed retrospectively clinical patient records and radiographs
of 47 OI patients, aged 1–19 years, some of whom were treated with bisphosphonates. Presence of joint hypermobility,
scoliosis, and craniovertebral anomalies was recorded and possible connections between the phenomena were
explored with correlation analysis.
Results: Joint hypermobility was found in 70% of the patients. Scoliosis and cranial base anomalies had developed in
26%. The presence of spinal complications was independent of the bisphosphonate treatment status and joint
hypermobility.
Conclusions: Scoliosis and craniovertebral anomalies are strongly associated in paediatric OI patients. Joint
hypermobility that is much more common appears, however, to be a poor predictor.
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Osteogenesis imperfecta (OI) is a heterogeneous group
of rare inherited connective tissue disorders of bone fra-
gility due to abnormal collagen composition. In addition
to bone, other tissues rich in collagen, including liga-
ments, skin, and cornea, may be affected. OI is charac-
terized by osteopenia and fractures, short stature, and
excessive ligament laxity [1]. Classification of OI is based
on the causative gene mutation and/or clinical and
radiological phenotype [2-4].
Joint hypermobility is defined as a range of movement
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unless otherwise stated.background [5]. The maximum range of movement of
a joint is determined by the morphology of the bones,
tightness of the capsule, and ligaments attached. The
primary cause of hypermobility is ligament laxity [5].
Females tend to be more lax than males, and the
degree of laxity decreases with age [6]. In European
paediatric population general ligament laxity is consid-
ered to be present in 5–35% of children [7,8]. Hyper-
mobility is commonly diagnosed with Beighton score
that evaluates the ability to perform a selection of
manoeuvers involving five different joints [6,9]. Vari-
ous degree of joint hypermobility is seen for instance
in different types of Ehlers-Danlos syndrome which,
alongside OI and Marfan syndrome, form a heterogeneous
group of heritable connective tissue disorders. In addition
to each possessing characteristic symptoms, considerableal. This is an Open Access article distributed under the terms of the Creative
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hyperextensibility and joint hypermobility. The latter is a
congenital feature that has been linked with instability of
the skeleton and with scoliosis [5].
Scoliosis is a common problem in OI, and affects
about half of the patient population [10,11]. One of the
most serious complications of OI is craniocervical path-
ology in the form of basilar impression or basilar inva-
gination. The condition may be asymptomatic or lead to
compression of the brain stem and/or related neurovas-
cular structures, resulting in a variety of subsequent
neurological complications and symptoms [12]. Platyba-
sia (flattening of the anterior cranial base) has been asso-
ciated with craniocervical junction pathology [13-15].
Early recognition of patients at risk of developing cra-
niocervical pathology and/or progressive scoliosis is
essential for the treatment planning. Our aim was to
evaluate how common joint hypermobility is in paediat-
ric patients with OI and to find out whether it serves as
a potential predictive marker of spinal pathology in the
form of scoliosis or craniovertebral anomaly.
Methods
This retrospective cross-sectional one-center study was
carried out at the Children's Hospital, Helsinki Univer-
sity Central Hospital, Finland. The study was approved
and consent for the use of patient records was given by
the Research Ethics Committee, Children’s Hospital,
Helsinki University Hospital. The study group consisted
of patients with OI, who are or have previously been
under follow-up at the Metabolic Bone Clinic, Children’s
Hospital during the years 1996–2013. The inclusion cri-
teria were 1) diagnosis of OI, 2) availability of radio-
graphic data on the cranium, and 3) age between one
and 19 years at the time of imaging.
Altogether 47 patients fulfilled the inclusion criteria.
Their patient files were reviewed to obtain data on the
OI type, presence of joint hypermobility, spinal deform-
ity, bisphosphonate treatment history, and neurological
status. Classification of the OI type was based on clinical
and radiological features as well as available genetic data,
and grouped as mild, moderate, or severe. When radio-
logical longitudinal follow-up data were available (25 pa-
tients), the most recent radiograph and medical record
notes at the time point were included in the cross-
sectional data. The height measurements of the patients
were converted to age- and sex-specific Z-scores accord-
ing to Finnish references [16].
The decision of bisphosphonate treatment was made
individually based on the severity of the disorder and
symptoms. According to local guidelines, the patients
were eligible for treatment if they had (1) a history of
frequent fractures, (2) vertebral compression fractures,
(3) chronic disabling bone pain, and/or (4) theirvulnerability to fractures was estimated high. Both
intravenously and orally administered bisphosponates
have been used for treatment of OI in Finland since the
year 2001.
Diagnosis of scoliosis was made on the basis of clinical
and radiological findings by a paediatrician and/or paedi-
atric orthopaedic surgeon. In clinical examination, the
angle of trunk inclinations was recorded in forward
bending position with a scoliometer at the upper thor-
acic (T3-T4) and at the thoraco-lumbar (T12-L1 or L2-
L3) levels. Radiographs of the spine were obtained when
severe scoliosis or kyphosis was suspected based on clin-
ical examination. Scoliosis was recorded when the spinal
inclination exceeded 6 degrees as measured with a scoli-
ometer or 10 degrees in radiographic evaluation of the
coronal plane [17]. Diagnosis of joint hypermobility was
made based on clinical findings of the large joints by a
paediatrician and/or paediatric orthopaedic surgeon.
Patients with Beighton score of four out of nine or
higher were diagnosed as hypermobile. Diagnosis of cra-
nial anomaly was done from mid-sagittal skull radio-
graphs based on three previously documented reference
line measures: 1) McRae measure to diagnose the pres-
ence of basilar invagination, 2) D-M angle to diagnose
basilar impression, and 3) anterior cranial base angle to
diagnose platybasia. An anomaly was present when
McRae measure was at or above 0, or either of the angu-
lar measure values exceeded 2.5 SD from that of age-
specific norms, thus indicating an abnormally high
position of the odontoid process or an abnormally flat
cranial base [18].
For statistical analysis, presence of joint hypermobility,
scoliosis, and cranial anomalies were classified as dichot-
omous variables (yes/no). Associations between the vari-
ables were computed with phi correlation coefficient.
Association between joint hypermobility and height Z-
score was computed with point-biserial correlation coef-
ficient (SPSS software version 19; SPSS Inc., Chicago, IL,
USA).
Results
The majority of the patients (64%) represented mild OI
(type I), 21% had moderate OI (types IV and VI), and
15% had severe OI (type III). Their mean height Z-
scores were in line with the general severity of the dis-
order as documented in previous studies [19]. Joint hy-
permobility was present in 70% of patients, and scoliosis
in 26% of patients. Of the patients, 26% (12 patients)
had at least one form of cranial anomaly (basilar impres-
sion, basilar invagination, or platybasia). Nine patients
exhibited platybasia, eight patients exhibited basilar im-
pression, and seven patients basilar invagination.
The prevalence of joint hypermobility was independ-
ent of the severity of OI, whereas scoliosis and cranial
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and severe OI types than in the mild OI type (Table 1).
The results of the phi coefficient analysis on the whole
patient material indicated no association between joint
hypermobility and scoliosis (Phi = −0.152, p = 0.30, n =
47) or between joint hypermobility and cranial anomal-
ies (Phi = −0.221, p = 0.13). No association was found
between joint hypermobility and height Z-score (rpb =
0.113, p = 0.45, n = 47). A significant positive correlation
was, however, detected between scoliosis and presence
of some form of cranial anomaly (Phi = 0.511, p = 0.00).
Of the 47 patients, 30 (64%) had been treated with
bisphosphonates. Most of the patients were treated with
intravenous bisphosphonates (pamidronate and zoledro-
nic acid) and only 2 patients received an oral preparation
(risedronate). The average treatment time was 4.3 years
(range 0.2 – 10.8 years) prior to cranial imaging. Charac-
teristics of the patients treated with bisphosphonates are
depicted in Figure 1. In this subgroup of patients, the
results of the phi coefficient analysis indicated similarly
no association between joint hypermobility and scoliosis
(Phi = −0.04, p = 0.81, n = 30), or joint hypermobility and
cranial anomalies (Phi = −0.005, p = 0.98). A significant
positive association was again detected between scoliosis
and the presence of a cranial anomaly (Phi = 0.92, p =
0.00).
Of the 25 patients with longitudinal follow-up data on
skull base morphology, 19 patients (76%) had been
treated with bisphosphonates. The six patients that had
not received bisphosphonates were treated in the Chil-
dren’s Hospital at a time when bisphosphonates were
not generally used in the treatment of OI. Of the pa-
tients treated with bisphosphonates, four had developed
platybasia and scoliosis by the ages of 7, 8, 13.5, and
18 years, respectively, and one had developed only scoli-
osis by the age of 9 years during the follow-up. The
youngest patient diagnosed with scoliosis was 3.8 years
at the time of the diagnosis. She had severe OI and had
been treated with bisphosphonates since one month of
age and was able to sit supported in a wheelchair. FourTable 1 Summary of the OI patient cohort, medication data, a
Mild (type
Number of patients 30
Age range at skull imaging (years) 1.3-18.1
Mean height Z-score −0.8
Number of patients treated with bisphosphonates 18
Mean duration and range of bisphosphonate treatment prior
to imaging (years)
3.6 (0.1-8.3
Number of patients with hypermobile joints 22 (73%)
Number of patients with scoliosis 3 (10%)
Number of patients with cranial anomaly 2 (6.7%)of these six patients that developed scoliosis despite bis-
phosphonate treatment also had hypermobile joints. Of
the six patients that had not received bisphosphonates
three developed scoliosis at the ages of 4, 9, and 9 years.
One of them also had hypermobile joints. In total, of the
25 patients with longitudinal follow-up, 16 were diag-
nosed with joint hypermobility (64%) and 14 (56%) de-
veloped a spinal complication. Hypermobility and spinal
complications co-emerged in six patients.
Discussion
Patients with OI commonly present with varying degree
of ligament laxity. We found joint hypermobility to be
such a frequent finding that it could not serve as a pre-
dictive marker for the more rare spinal complications,
and it was equally prevalent in mild and severe types of
OI. The prevalence of joint hypermobility in patients
with OI, not treated with bisphosphonates, has previ-
ously been reported to be 34% [10]. In our patient ma-
terial, with a similar age range, joint hypermobility was
more common with a prevalence of 70%. Our findings
are consistent with those of Brizola and co-workers, who
found joint hypermobility in 58 – 100% of paediatric pa-
tients, most of whom had been treated with intravenous
bisphosphonates [20]. The group used a Beighton score
of five as the cut-off value. Several studies have indicated
that bisphosphonate treatment reduces the number of
fractures in children with OI [21,22]. Thus the reported
smaller prevalence of joint hypermobility in the un-
treated patients might be attributed to relative or actual
joint stiffness caused by numerous bone fractures and
deformities. This hypothesis is supported by the reported
generalized reduction in joint range of motion in un-
treated patients with moderate and severe OI [23,24].
The prevalence of spinal deformity in children with OI
has been documented to range between 39 and 100%
[10,25,26]. The aetiology of the spinal curvatures re-
mains disputable. Vertebral fractures and deformity, as
well as muscular weakness and ligament laxity, are all
believed to contribute to the development of spinalnd findings
I) Moderate (types IV, VI) Severe (type III) Total
10 7 47
9.2-18.8 3.8-8.6 1.3-18.8
−4.0 −5.4 −2.2
8 4 30
) 3.2 (0.2-10.9) 3.2(2.2-4) 0.7 (0.1-10.9)
6 (60%) 5 (71%) 33 (70%)
5 (50%) 4 (57%) 12 (26%)
5 (50%) 5 (71%) 12 (26%)
Figure 1 Data on the bisphosphonate-treated patients (n = 30); green color indicates mild OI type, purple color moderate type, and
blue color severe OI type.
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have been documented to be less frequent in children
with OI and generalized joint hypermobility than in
those with normal joints [10]. Based on this, Engelbert
and co-workers suggest that microfractures of the verte-
brae play an important role in the development of spinal
complications [10]. Contrary to this conclusion, other
studies have proposed laxity of spinal ligaments to result
in vertebral instability and thus underlie progressive
spinal curvature [27,28]. Moreover, vertebral body shape
has been outlined as a predictor of spinal deformity in
patients with OI [26].
Scoliosis is more common in the more severe forms of
OI and a rare finding in patients under the age of five,
and [27,29]. After the age of six, a rapid progression of
scoliosis is observed in patients not treated with bispho-
sphonates [27]. Our findings are in agreement with these
in that only two children both suffering from severe OI
developed scoliosis under the age of six years.
Cranial base anomalies have been found to be present
in more than one third of patients with OI regardless of
bisphosphonate treatment status [18,30]. In children
with OI, craniocervical pathology is an acquired anomaly
that has been detected from the age of two years, corre-
sponding with the delay in age at which a child with a
severe form of OI attains an upright position [19,23,31].
Children with mild form of OI, on the other hand, reach
motor milestones at a rate close to that of healthy peers
[32]. The pathogenesis of cranial base anomalies and the
factors predisposing to their development are unknown.
Basilar impression has been suggested to be more com-
monly associated with kyphosis than with scoliosis in
paediatric OI patients not treated with bisphosphonates
[10]. In this study, seven out of the eight patients with
basilar impression also displayed basilar invagination
and/or platybasia.Very little published data are available on craniocervi-
cal anomalies in other syndromes of joint hypermobility
that would shed light on the pathogenesis of craniocervi-
cal anomalies. Prevalence of basilar impression in pa-
tients with Marfan syndrome has been stated to be 36%,
and prevalence of focal kyphosis 16% [33]. Nevertheless,
in only 11% of the patients with Marfan syndromethe tip
of the odontoid extended a minimum of 7 mm above
Chamberlain’s line, which is the upper limit found in
normal population and the criterion of basilar impres-
sion is possibly fulfilled due to a morphological bone
anomaly of enlarged odontoid. Patients with Marfan syn-
drome have been observed to display greater atlantoaxial
range of movement and an increased incidence of atlan-
toaxial or C2/C3 translocation in radiographic examin-
ation of the cranium in flexion and extension [33]. Basilar
headache, neck pain, and other typical related clinical
problems are, however, rare. Atlantoaxial hypermobility
has been found to be more common in children with Mar-
fan syndrome than in adults corresponding with the nor-
mally occurring stiffening of the ligaments with age [33].
Treatment with bisphosphonates has been shown to
improve mobility, level of ambulation, and muscle force
in children with moderate to severe OI [34]. The treat-
ment also induces growth in children with OI, as the
collapsed vertebral bodies regain a more normal size and
shape [35-37]. In the study of Åström and colleagues no
child developed scoliosis, kyphosis or basilar impression
after the onset of bisphosphonate treatment, and scoli-
osis remained unchanged in an infant diagnosed with it
prior to treatment. In the study, median duration of
follow-up was 4.5 years [38]. Anissipour and co-workers
found that bisphosphonate treatment started early, be-
fore the age of six years, in children with severe OI, de-
creased significantly the progression rate of the scoliotic
curve, whereas in older patients and in patients with
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effect on the progression of scoliosis [11]. The present
finding is thus consistent with the previous report on the
unchanged overall prevalence of scoliosis following bis-
phosphonate treatment [11]. In growing patients the oc-
currence of scoliosis has been found to correlate with low
bone mineral density [29]. In contrast, Engelberg and col-
leagues reported that patients with considerably low bone
mineral density in association with moderate and severe
OI were diagnosed with both platyspondyly and joint hy-
permobility but yet did not all develop scoliosis [39]. The
group found delayed motor development as a risk indica-
tor for developing scoliosis in untreated children. Hence,
the findings on overall effects of bisphosphonate treat-
ment on craniovertebral anomalies are controversial and
the protective effect of bisphosphonates on the develop-
ment of scoliosis is yet to be determined.
The limitations of our study are the relatively small
number of patients due to rarity of OI, and the lack of
systematic radiographic evaluation of the spine and
cranium in extension and flexion. The radiographs had
been obtained on clinical indications for diagnostics
and planning of treatment to retain the radiation dose
of the patients at minimum. Clinical evaluation of sco-
liosis may leave some mild spinal curvature unnoticed,
but it is unlikely that severe scoliosis would have
remained undiagnosed. This applies even to joint hyper-
mobility: mild hypermobility may remain undetected while
severe forms are recorded. The retrospective nature of our
study prevented a more standardized and systematic evalu-
ation of joint hypermobility and scoliosis. The methods
used for clinical evaluation of scoliosis and radiological
analysis of craniocervical pathology have been previously
documented to be reliable [40,41].
Conclusions
The standpoint of this paper was to assess how prevalent
hypermobility is in patients with OI, and whether hypermo-
bility could, at least partly, explain the less well-known aeti-
ology of the spinal complications in OI. Our present
finding that scoliosis and cranial base pathology develop in
some patients despite bisphosphonate treatment would in-
deed suggest that a non-osseous factor, such as ligament
laxity, plays an important role. Nevertheless, we found joint
hypermobility in 70% of children with OI, and that contrary
to spinal complications, it was not over represented in se-
vere forms of OI. Presence of joint hypermobility was not
found to correlate with the presence or appearance of ei-
ther scoliosis or cranial base pathology. Hence, the general
severity of the disease remains thus far the best way to
predict the development of spinal complications.
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